No photo of Barry Kreiswirth

View Scopus Profile

Barry Kreiswirth

Ph.D.

  • 35193 Citations
  • 95 h-Index
1982 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Barry Kreiswirth is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

A dual-beta-lactam strategy for treating multidrug resistant M abscessus

Kreiswirth, B.

National Institutes of Health

8/15/19 → 7/31/23

Project: Research project

    • Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents

    Kreiswirth, B., Dartois, V., Ebright, R., Freundlich, J., Perlin, D., Dick, T., Alland, D., Brady, S. & Roemer, T.

    National Institutes of Health

    5/1/19 → 4/30/24

    Project: Research project

    • Unraveling colistin resistance in Klebsiella pneumoniae

    Kreiswirth, B.

    National Institutes of Health

    1/15/18 → 12/31/20

    Project: Research project

    • The molecular basis of epidemic blaKPC Klebsiella pneumoniae and Enterobacteriace

    Kreiswirth, B.

    National Institutes of Health

    9/29/10 → 11/30/21

    Project: Research project

    • A rapid molecular approach to determine PZA susceptibility

    Kreiswirth, B.

    National Institutes of Health

    6/1/13 → 5/31/15

    Project: Research project

    • Research Output

    A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy

    Lenhard, J. R., Rana, A. P., Wenzler, E., Huang, Y., Kreiswirth, B. N., Chen, L. & Bulman, Z. P., Sep 2020, In : Diagnostic Microbiology and Infectious Disease. 98, 1, 115080.

    Research output: Contribution to journal › Article

    • ARGONAUT II study of the in vitro activity of plazomicin against carbapenemase-producing klebsiella pneumoniae

    Jacobs, M. R., Good, C. E., Hujer, A. M., Abdelhamed, A. M., Rhoads, D. D., Hujer, K. M., Rudin, S. D., Domitrovic, T. N., Connolly, L. E., Krause, K. M., Patel, R., Arias, C. A., Kreiswirth, B. N., Rojas, L. J., D'Souza, R., White, R. C., Brinkac, L. M., Nguyen, K., Singh, I., Fouts, D. E. & 2 others, Van Duin, D. & Bonomo, R. A., May 2020, In : Antimicrobial agents and chemotherapy. 64, 5, e00012-20.

    Research output: Contribution to journal › Article

    • Co-occurrence of plasmid-mediated tigecycline and carbapenem resistance in Acinetobacter spp. From waterfowls and their neighboring environment

    Cui, C. Y., Chen, C., Liu, B. T., He, Q., Wu, X. T., Sun, R. Y., Zhang, Y., Cui, Z. H., Guo, W. Y., Jia, Q. L., Li, C., Kreiswirth, B. N., Liao, X. P., Chen, L., Liu, Y. H. & Sun, J., May 2020, In : Antimicrobial agents and chemotherapy. 64, 5, e02502-19.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Core genome MLST and resistome analysis of Klebsiella pneumoniae using a clinically amenable workflow

    the Antibacterial Resistance Leadership Group, May 2020, In : Diagnostic Microbiology and Infectious Disease. 97, 1, 114996.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections

    Shields, R. K., McCreary, E. K., Marini, R. V., Kline, E. G., Jones, C. E., Hao, B., Chen, L., Kreiswirth, B. N., Doi, Y., Clancy, C. J. & Nguyen, M. H., Jul 27 2020, In : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 71, 3, p. 667-671 5 p.

    Research output: Contribution to journal › Article

    • 6 Scopus citations